Opportunity

SAM #75N98026Q00237

Preclinical Toxicity Testing of Six Novel Drugs by Jai Research Foundation

Buyer

NIH Office of Logistics and Acquisition Operations

Posted

April 21, 2026

Respond By

May 01, 2026

Identifier

75N98026Q00237

NAICS

541715, 541714, 541380

The National Institutes of Health (NIH), Office of Logistics and Acquisition Operations (OLAO), is announcing a procurement for preclinical toxicity testing of six novel drugs. - Government Buyer: - Department of Health and Human Services, National Institutes of Health (NIH) - Office of Logistics and Acquisition Operations (OLAO) - Laboratory of Bioorganic Chemistry - OEMs and Vendors: - Jai Research Foundation (highlighted as the intended awardee and service provider) - Products/Services Requested: - Preclinical toxicity testing for six new novel drugs - Includes safety, solubility, and bioavailability assessments - Testing must follow protocols consistent with previous studies to ensure data comparability - Unique or Notable Requirements: - Continuity with prior testing is required for data consistency - This is the third contract with Jai Research Foundation for similar work - The notice is not a request for competitive quotes, but small businesses may submit capability statements - Place of Performance: - National Institutes of Health facilities in Bethesda, Maryland - Contracting office located at 6011 Executive Blvd., Suite 503L, Bethesda, MD 20892

Description

Attachment: Notice of Intent

View original listing